
Release date: 2026-04-03 16:46:43 Article From: Lucius Laos Recommended: 7
Although the specific dosage must be determined by your doctor based on your individual circumstances (including blood phosphorus levels, body weight, side effects, etc.), erdafitinib is typically taken once daily as an oral tablet. Follow the prescription strictly and do not increase or decrease the dose on your own. During treatment, you may need regular blood tests to monitor your complete blood count, liver and kidney function, and blood phosphorus levels. If serious side effects occur, your doctor may temporarily interrupt treatment, reduce the dose, or permanently discontinue the drug. Additionally, keep erdafitinib out of the reach of children. If you miss a dose, consult your doctor or pharmacist for advice—do not double the dose on your own. While on treatment, avoid foods that may affect drug absorption (e.g., foods high in phosphorus may need to be restricted, follow your doctor’s specific advice).
You are not alone during treatment. The official erdafitinib website and patient support programs can provide a variety of resources. You can also ask your doctor or pharmacist about support groups or care coordination services available for patients taking erdafitinib. Accessing these resources can help you better cope with treatment challenges and improve your quality of life. Take the initiative to ask your doctor or the pharmaceutical company’s customer service hotline about available support programs.
Sometimes, medications may be used for purposes not listed in the patient information leaflet. However, do not use erdafitinib for conditions not prescribed by your doctor, and do not give this medicine to others, even if they have the same symptoms as you, as it may harm them. If you would like more information, speak with your healthcare provider. You can also ask your pharmacist or doctor for the detailed prescribing information for erdafitinib written for medical professionals. Click the link for full prescribing information (or scan the QR code) to read all the details. Only by working closely with your medical team can the safety and effectiveness of targeted therapy be ensured. Promptly report any unusual symptoms to your doctor, and never stop taking the medication or change the dose on your own.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2172025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4502024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2242025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2392025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2182025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:2462025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2292025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2142025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: